Stage IE malignant lymphoma of the testis: a clinical study of three cases.
|
Accession number;99A0299767
|
| Title;Stage IE malignant lymphoma of the testis: a clinical study of three cases. |
| Author;
NISHITANI MASAAKI
(Univ. of Tokushima, Sch. of Med.)
INOUE YOSHIO
(Univ. of Tokushima, Sch. of Med.)
KANDA KAZUYA
(Univ. of Tokushima, Sch. of Med.)
MURAKAMI YOSHIHIDE
(Univ. of Tokushima, Sch. of Med.)
KANAYAMA HIROOMI
(Univ. of Tokushima, Sch. of Med.)
KAGAWA SUSUMU
(Univ. of Tokushima, Sch. of Med.)
|
Journal Title;Nishinihon Journal of Urology
|
Journal Code:Z0253B
|
ISSN:0029-0726
|
|
VOL.61;NO.2;PAGE.135-138(1999)
|
| Figure&Table&Reference;FIG.2, TBL.3, REF.9 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;We treated 61 patients with testicular tumors at our hospital between 1982 and 1997. Malignant lymphoma of the testis accounted for 11.5% (7 cases) of the testicular tumors in our patients but for 58.3% of those in men older than 50 years (55-79 years old). Among these 7 patients, 5 had primary tumors, including 3 at stage IE and the other 2 had secondary tumors. Immunohistochemistry revealed that the primary tumors were B cell-derived and the secondary tumors were T cell-derived. Of the 3 stage IE cases, two underwent adjuvant chemotherapy, experiencing relapse 84 months and 89 months later. The patients died of lymphoma. Stage IE malignant lymphoma of the testis has a worse prognosis, and therefore adjuvant chemotherapy and long-term follow-up should be considered in these cases. (author abst.) |
|
|
|
Related Articles;
|
|
